ArticleExperimental & molecular medicine2024

Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma.

Hyondeog Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.